Topics:

Emerging Infectious Diseases

Emerging Infectious Diseases

Summertime is peak time for methicillin-resistant Staphylococcus aureus infections. Also, a suggested strategy for addressing vancomycin resistance.

The use of whole-genome sequencing for infection control in a special care baby unit is only one example of how DNA sequencing is beginning to improve outbreak control in the real world.

Weight-based vancomycin dosing for methicillin-resistant Staphylococcus aureus may not be the best strategy, guidelines notwithstanding.

New research suggests that community-associated methicillin-resistant Staphylococcus aureus is often a family affair.

Another antibiotic is showing promise at treating methicillin-resistant Staphylococcus aureus (MRSA) strains that are also resistant to the usual last-resort drug, vancomycin.

Reports within the past few months confirm that, although it may be classed as an epidemic, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is coming under control.

Subscribe to Emerging Infectious Diseases on [sitename]
Please Wait 20 seconds or click here to close